Skip to content

Clinical trials

Observational Hepatic Encephalopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatic Encephalopathy Phase: Observational Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20123
20132
20171
20181
20192
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Withdrawn2
Enrolling by invitation1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NYU Langone Health3
OSF Healthcare System1
Power Life Sciences Inc.1
Prof. Valérie Mc Lin1
Stanford University1
University of Arkansas1
University of Illinois at Chicago1
University of Michigan1
University of Pittsburgh1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatic Encephalopathy12
Fibrosis6
Ascites2
Fatigue2
Hypertension, Portal2
Brain Diseases1
Congenital Portosystemic Shunt1
Esophageal and Gastric Varices1
Hemorrhage1
Hepatitis C1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.